Professor Dr. Gopal Natesan is a highly experienced and motivated researcher with over 23 years of expertise in academic, administration and research activities. He is working as Director, Institute of Pharmacy, Nirma University. He completed his Master's in Pharmacy (Pharmaceutical Chemistry) and earned his Doctorate in Pharmaceutical Chemistry from Jamia Hamdard, New Delhi, in 2001. He has completed Post graduate certificate in Teaching & Learning from Anglia Ruskin University, UK in 2016 and Master of Business Administration (MBA) from MAHSA University in 2022. He is Fellow of The Higher Education Academy, UK Professional Standards Frame work, UK since 2016. His research focuses on the synthesis of newer small chemical entities, quinazolinones heterocyclic pharmacophore and their preliminary screening in both in-vivo and in-vitro models mainly focusing on pain & inflammation, cancer and microbial agents. He has published >50 articles in indexed journals and presented >98 papers in International & National conferences. He has completed several funded and non-funded research projects for degree and post graduate levels and recently filed 2 patents in India (2021) and 1 research patent granted from South Africa in 2022. He has received number of honours for his research work, specifically in 2013, he has honoured “Young Scientist Award” by the International Society of Nature & Health Care Inc, USA, University of Colombo and University of Kelaniya, Sri Lanka and in 2017 he was awarded with “Edward Kennedy Memorial Award” in 2nd Global Cancer Summit, Kuala Lumpur. Recently on 17th December 2022, he was honoured “Outstanding Scientist Award” in International Eminent Awards on Engineering, Science and Medicine, India. Prof. Gopal serves as an editorial board member, peer reviewer, and appointed as Chairman for the different International Conferences and also as Organizing Committee member. He has held numerous senior academic positions in India and abroad and supervised postgraduate students from the Master to Ph.D. levels.